ID.1
Item
clinical or histologic diagnosis of bcc
boolean
C0007117 (UMLS CUI [1])
ID.2
Item
patient dependent exclusion criteria:
boolean
C0680251 (UMLS CUI [1])
ID.3
Item
> 5 bccs at presentation
boolean
C0007117 (UMLS CUI [1,1])
C0750480 (UMLS CUI [1,2])
ID.4
Item
immunosuppressive drugs
boolean
C0021081 (UMLS CUI [1])
ID.5
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
ID.6
Item
disability to give informed consent
boolean
C0021430 (UMLS CUI [1])
ID.7
Item
synchronous participation in other studies
boolean
C0681850 (UMLS CUI [1])
ID.8
Item
progeroid syndromes
boolean
C0009207 (UMLS CUI [1])
ID.9
Item
other malignant tumors, except for bcc and squamous cell carcinoma, or monoclonal neoplasms of the hematopoietic or immune system
boolean
C0007097 (UMLS CUI [1])
ID.10
Item
critical illness precluding sufficient follow-up visits
boolean
C0010340 (UMLS CUI [1])
ID.11
Item
tumor exclusion criteria:
boolean
C0680251 (UMLS CUI [1])
ID.12
Item
recurrent bcc
boolean
C1304307 (UMLS CUI [1])
ID.13
Item
nodular bcc with an exophytic part of > 1.5 mm above skin level
boolean
C0007117 (UMLS CUI [1,1])
C0489786 (UMLS CUI [1,2])
ID.14
Item
nodular bcc with a diameter of > 10 mm
boolean
C0007117 (UMLS CUI [1,1])
C0456389 (UMLS CUI [1,2])
ID.15
Item
superficial bcc with a diameter of > 20 mm
boolean
C0007117 (UMLS CUI [1,1])
C0456389 (UMLS CUI [1,2])
ID.16
Item
ulceration
boolean
C0041582 (UMLS CUI [1])
ID.17
Item
scarring
boolean
C0022548 (UMLS CUI [1])
ID.18
Item
blurred margins
boolean
C1708506 (UMLS CUI [1])
ID.19
Item
histopathologic evidence of a tumor type different from nodular or superficial bcc
boolean
C0677043 (UMLS CUI [1])